Detalhe da pesquisa
1.
Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11.
Hepatology
; 68(6): 2158-2166, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30070726
2.
The Drug-Drug Interaction Potential of Antiviral Agents for the Treatment of Chronic Hepatitis C Infection.
Drug Metab Dispos
; 46(8): 1212-1225, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29695614
3.
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus.
J Gastroenterol Hepatol
; 31(7): 1323-9, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26841930
4.
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection.
J Hepatol
; 63(2): 320-8, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25733157
5.
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial.
J Viral Hepat
; 21(11): 762-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25196837
6.
Organic Anion Transporting Polypeptide Inhibition Dramatically Increases Plasma Exposure but not Pharmacodynamic Effect nor Inferred Hepatic Intracellular Exposure of Firsocostat.
Clin Pharmacol Ther
; 109(5): 1334-1341, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33141923
7.
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus.
Hepatol Int
; 10(6): 947-955, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27198664
8.
Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS.
J Pharm Sci
; 104(9): 3229-35, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26010239